Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -16.237% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. Cc1nn(-c2ccccc2)nc1CNC(=O)C1CCC1
b. N#CC(Cc1ccccc1OC(F)F)c1nc2ccccc2[nH]1
Answer: b. N#CC(Cc1ccccc1OC(F)F)c1nc2ccccc2[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#CC(Cc1ccccc1OC(F)F)c1nc2ccccc2[nH]1
N#CC(Cc1ccccc1OC(F)F)c1nc2ccccc2[nH]1
3-[2-(difluoromethoxy)phenyl]-2-(1H-benzimidazol-2-yl)propanenitrile